E-ISSN 2146-9369 | ISSN 2146-3158
 
2024, Vol: 14, Issue: 1
14 / 1Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Research Article 


Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma.

Cited By:4

Abstract
Objectives:Escherichia coli and some Salmonella enterica serovars are zoonotic pathogens affecting livestock and humans. These pathogens cause significant loss of productivity in livestock, severe morbidity and mortality in humans, and have high antibiotic resistance profiles. Therefore, the exploitation of lytic phages for therapeutic purposes is important for eliminating these resistant bacterial strains.<br>Methods: Thirty-four bacterial stock isolates comprised of 23 E. coli and 11 Salmonella spp. strains were evaluated for antimicrobial susceptibility to seven antibiotics using the Kirby-Bauer disk diffusion test. The antibiotics included Ciprofloxacin, Trimethoprim-Sulphamethoxazole, Gentamycin, Imipenem, Ceftriaxone, Cefotaxime, and Ofloxacin. Twelve (12/23) E. coli and (2/11) Salmonella spp. exhibited antimicrobial resistance. Selected six (6/12) drug-resistant E. coli strains were subjected to three different phages (PA5, EHEC005, C11S1A) for efficacy and host range assay. Similarly, two (2/2) resistant Salmonella strains were exposed to one Salmonella phage A23 for efficacy and host range assay. The E. coli (C11S1A) phage, which infected most bacterial hosts, was evaluated for optimal efficiency at various pH and temperatures.<br>Results:E. coli isolates had the highest resistance 12/23 (52%) compared to Salmonella spp. 2/11(18%) (p<0.05). Most resistance was against Trimethoprim-Sulphamethoxazole (44%) and (9%) for E. coli and Salmonella spp., respectively. Furthermore, E. coli (C11S1A) phages killed all the Escherichia coli strains, while Salmonella phage A23 only lysed the host bacteria. The E. coli (C11S1A) phages were highly efficacious at 37 0C and pH 7.4.<br>Conclusion: The successful isolation of novel lytic E. coli (C11S1A) phages, which killed all the E. coli strains tested, demonstrates the potential for therapeutic purposes for humans and livestock. J Microbiol Infect Dis 2021; 11(4):183-190.

Key words: Antimicrobial resistance, zoonosis, novel bacteriophage, East Africa


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Atunga Nyachieo
Articles by Stephen Alafi
Articles by Ivy Jepkurui Mutai
Articles by Benson Ngolobe
Articles by Ritah Nabunje
Articles by Jesca L. Nakavuma
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. J Microbiol Infect Dis. 2021; 11(4): 183-190 . doi:10.5799/jmid.1036727

Web Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. https://www.jmidonline.org/?mno=302656976 [Access: February 02, 2024]. doi:10.5799/jmid.1036727

AMA (American Medical Association) Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. J Microbiol Infect Dis. 2021; 11(4): 183-190 . doi:10.5799/jmid.1036727


Vancouver/ICMJE Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. J Microbiol Infect Dis. (2021), [cited February 02, 2024]; 11(4): 183-190 . doi:10.5799/jmid.1036727


Harvard Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma (2021) Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. J Microbiol Infect Dis, 11 (4), 183-190 . doi:10.5799/jmid.1036727


Turabian Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. 2021. Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. Journal of Microbiology and Infectious Diseases, 11 (4), 183-190 . doi:10.5799/jmid.1036727


Chicago Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. "Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.." Journal of Microbiology and Infectious Diseases 11 (2021), 183-190 . doi:10.5799/jmid.1036727


MLA (The Modern Language Association) Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma. "Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.." Journal of Microbiology and Infectious Diseases 11.4 (2021), 183-190 . Print. doi:10.5799/jmid.1036727


APA (American Psychological Association) Style

Atunga Nyachieo, Stephen Alafi, Ivy Jepkurui Mutai, Benson Ngolobe, Ritah Nabunje, Jesca L. Nakavuma (2021) Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.. Journal of Microbiology and Infectious Diseases, 11 (4), 183-190 . doi:10.5799/jmid.1036727


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesPeer Review PolicyPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About Journal of Microbiology and Infectious Diseases

Journal of Microbiology and Infectious Diseases (JMID) is an international "peer review" journal in microbiology, infectious diseases, virology, ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes

Editor-in-Chief

Journal of Microbiology and Infectious Diseases

Department of Microbiology and Parasitology 

Faculty of Veterinary Medicine

University of Tripoli

P.O. Box 13662, Tripoli, Libya